RxDoctor Payments DataLook up a doctor →

Flebogamma DIF: payments to doctors

Payments that named Flebogamma DIF as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$177K
Providers
28
Transactions
180
Average per transaction
$985

The per-transaction average — $985 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 28 providers the average total is $6,330, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Grifols Shared Services North America, Inc.$86,47748.8%
Grifols Biologicals LLC$76,20243.0%
Grifols, S.A.$12,0866.8%
Grifols Therapeutics LLC$2,4731.4%
← All drugs & devices